*Some Market data delayed by 15 mins.

NextCure, Inc. Common Stock

Symbol: NXTC (NASDAQ)
5.80 ▼ (-0.96%) -0.056

Company Description:
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.

Key Stats
  • Today's Open: $5.788
  • Today's High: $5.804
  • Today's Low: $5.788
  • Today's Volume: 0
  • Yesterday Close: $5.86
  • Yesterday High: $5.89
  • Yesterday Low: $5.5
  • Yesterday Volume: 2.94K
  • Last Min Volume: 0
  • Last Min High: $5.804
  • Last Min Low: $5.788
  • Last Min VWAP: $0
Company Profile
  • Name: NextCure, Inc. Common Stock
  • Website: https://www.nextcure.com
  • Listed Date: 2019-05-09
  • Location: BELTSVILLE, MD
  • Market Status: Active
  • CIK Number: 0001661059
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $15.68M
  • Round Lot: 100
  • Outstanding Shares: 2.68M
  • Asset Type: CS
RECENT FILINGS FOR NXTC
Filing Date Filing Type Format
2025-09-29 3/A View
2025-08-25 8-K View
2025-08-19 SCHEDULE 13G View
2025-08-19 3 View
2025-08-07 10-Q View
2025-08-07 8-K View
2025-07-29 EFFECT View
2025-07-29 424B2 View
2025-07-28 CORRESP View
2025-07-24 UPLOAD View
2025-07-18 S-3 View
2025-07-14 8-K View
2025-07-10 8-K View
2025-06-24 4 View
2025-06-24 4 View
2025-06-24 4 View
2025-06-24 4 View
2025-06-24 4 View
2025-06-24 4 View
2025-06-23 8-K View
Latest News on NXTC

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.